Cardiac resynchronization therapy in patients with cancer: A single cancer center experience
Authors:
- Nicholas KingNKNicholas King
- Meera KapadiaMKMeera Kapadia
- Scott SchubertSSScott Schubert
- Jerril JacobJJJerril Jacob
- Juhee SongJSJuhee Song
- Salil KumarSKSalil Kumar
- Leslie YnalvezLYLeslie Ynalvez
- Bharat KanthariaBKBharat Kantharia
- Anita DeswalADAnita Deswal
- Kaveh KarimzadKKKaveh Karimzad
Open Access
- 18 October 2025
- journal article
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (1) , 188-190
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30 CA016672)
This publication has 5 references indexed in Scilit:
- Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncologyCurrent Oncology Reports, 2022
- Outcomes of cardiac resynchronization therapy in patients with chemotherapy‐induced cardiomyopathyPacing and Clinical Electrophysiology, 2021
- Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced CardiomyopathyJAMA, 2019
- The Use of Cardiac Resynchronization Therapy in Cancer Patients with Heart FailureJournal of Clinical and Experimental Research in Cardiology, 2017
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004